Assessment of Cardiac Function in Pregnant Females of a Tertiary Care Hospital of East Uttar Pradesh: A Cross-sectional Study
Abstract
Introduction: Cardiovascular dysfunction, including heart failure (HF), is a significant contributor to maternal mortality and is a leading non- obstetric cause of death during pregnancy. The rates of cardiovascular disease (CVD) mortality have been increasing over the years, surpassing other pregnancy-related causes of death.
Objectives: The study was conducted to assess the cardiac function in pregnant females during their third trimester and determine the prevalence of cardiac disease among pregnant women.
Methods: The study was conducted among 260 pregnant women in their third trimester who were selected as per the predefined inclusion and exclusion criteria. A thorough physical examination was done and presenting complaints such as chest pain, breathlessness, palpitations, syncope, easy fatiguability, swelling of legs, orthopnoea, and paroxysmal nocturnal dyspnoea along with few biochemical markers were documented. Data collected during the study period, which spanned from July 1, 2021, to June 30, 2022, were subjected to appropriate statistical analysis.
Results: The study had predominantly lower socioeconomic housewives (63.1% multigravida and 36.9% primigravida). Cardiac symptoms were present in 4.6% of the subjects. About 5.8% had chronic cardiac conditions, among whom, congenital heart issues were seen in 26.7%, while 73.3% had acquired heart disease. Atrial septal defect was the most common congenital condition, and rheumatic heart disease, particularly mitral stenosis and regurgitation, prevailed in acquired cases.
Conclusion: The study demonstrated a 5.8% prevalence of cardiac disease in pregnant women during their third trimester, with acquired heart disease, particularly rheumatic heart disease, being more common than congenital heart disease.
References
Burlingame J, Horiuchi B, Ohana P, Onaka A, Sauvage LM. The contribution of heart disease to pregnancy- related mortality according to the pregnancy mortality surveillance system. J Perinatol. 2012;32:163-9. [PubMed] [Google Scholar]
Zöllner J, Curry R, Johnson M. The contribution of heart disease to maternal mortality. Curr Opin Obstet
Gynecol. 2013;25:91-7. [PubMed] [Google Scholar]
Knight M, Kenyon S, Brocklehurst P, Neilson J, Shakespeare J, Kurinczuk JJ. Saving lives, improving mothers’ care: lessons learned to inform future maternity care from the UK and Ireland confidential enquiries into maternal deaths and morbidity 2009– 12. Oxford, United Kingdom: National Perinatal Epidemiology Unit, University of Oxford; 2014. [Google Scholar]
Ruys TP, Cornette J, Roos-Hesselink JW. Pregnancy and delivery in cardiac disease. J Cardiol. 2013;61(2):107- 12. [PubMed] [Google Scholar]
Hilfiker-Kleiner D, Haghikia A, Nonhoff J, Bauersachs J. Peripartum cardiomyopathy: current management
and future perspectives. Eur Heart J. 2015;36:1090-7. [PubMed] [Google Scholar]
Lima FV, Parikh PB, Zhu J, Yang J, Stergiopoulos K. Association of cardiomyopathy with adverse cardiac events in pregnant women at the time of delivery. JACC Heart Fail. 2015;3:257-66. [PubMed] [Google Scholar]
Pieper PG, Balci A, Aarnoudse JG, Kampman MA, Sollie KM, Groen H, Mulder BJ, Oudijk MA, Roos-Hesselink JW, Cornette J, van Dijk AP, Spaanderman ME, Drenthen W, van Veldhuisen DJ; ZAHARA II Investigators. Uteroplacental blood flow, cardiac function, and pregnancy outcome in women with congenital heart
disease. Circulation. 2013;128(23):2478-87. [PubMed] [Google Scholar]
Hennessey KC, Ali TS, Choi E, Ortengren AR, Hickerson LC, Lee JM, Taub CC. Association between abnormal echocardiography and adverse obstetric outcomes in low-risk pregnant women. J Cardiovasc Dev Dis. 2022 Nov 15;9(11):394. [PubMed] [Google Scholar]
Gerber Y, Weston SA, Redfield MM, Chamberlain AM, Manemann SM, Jiang R, Killian JM, Roger VL. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA
Intern Med. 2015;175(6):996-1004. [PubMed] [Google Scholar]
Dunlay SM, Roger VL. Understanding the epidemic of heart failure: past, present, and future. Curr Heart Fail
Rep. 2014;11(4):404-15. [PubMed] [Google Scholar]
Mayama M, Yoshihara M, Uno K, Tano S, Takeda T, Ukai M, Kishigami Y, Oguchi H. Factors influencing
brain natriuretic peptide levels in healthy pregnant women. Int J Cardiol. 2017;228:749-53. [PubMed] [Google Scholar]
Birhanu T, Dukesa T, Tegene E, Kabeta T, Markos Y. Prevalence of cardiovascular diseases among pregnant women attending antenatal care in Jimma University Medical Center, Southwest Ethiopia. Research Square:rs.3.rs-1639429/v1 [Preprint]. 2022 [cited 2023 May 13]. Available from: https://doi.org/10.21203/ rs.3.rs-1639429/v1 [Google Scholar]
Gomathi T, Thendral V. A study of screening echocardiography in asymptomatic pregnant women. Indian J Obstet Gynecol Res. 2019;6(4):440- 3. [Google Scholar]
Otto H, Saether SG, Banteyrga L, Haugen BO, Skjaerpe T. High prevalence of subclinical rheumatic heart disease in pregnant women in a developing country: an echocardiographic study. Echocardiography. 2011 Nov;28(10):1049-53. [PubMed] [Google Scholar]
Nascimento BR, Sable C, Nunes MC, Oliveira KK, Franco J, Barbosa MM, Reese AT, Diamantino AC, Ferreira
Filho DS, Macedo FV, Raso LA, Paiva SM, Ribeiro AL, Beaton AZ. Echocardiographic screening of pregnant women by non-physicians with remote interpretation in primary care. Fam Pract. 2021 Jun 17;38(3):225-30.
[PubMed] [Google Scholar]
Copyright (c) 2023 Jyoti Yadav, Aradhana Singh, Madhavi Sarkari, Raj Kishore Singh, Mudit Chauhan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
